Not much of a poster here in recent years, but have been in DXB since 2016.
The inconclusive result in DKD the Phase 2 trial in 2020 was a disappointment (more a frustration since it might well have been the result of DMX-200 providing unexpected residual benefit post dosing). Dimerix took this in its stride - DKD on the backburner and full steam ahead with FSGS.
Now we are at another inflection point: if the current trial results are positive and the FDA approves Phase 3, we could see a step change in Dimerix - not only running the FSGS trial, but also having the resources to revisit DKD and maybe even start pre-clinical work on DMX-700. DKD itself is a huge potential market.
- Forums
- ASX - By Stock
- Dimerix (ASX: DXB) Discussion Thread
Not much of a poster here in recent years, but have been in DXB...
-
- There are more pages in this discussion • 125 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
|
|||||
Last
55.0¢ |
Change
-0.060(9.84%) |
Mkt cap ! $302.3M |
Open | High | Low | Value | Volume |
60.5¢ | 61.0¢ | 55.0¢ | $2.309M | 4.010M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 137019 | 55.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
55.5¢ | 22500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 130691 | 0.550 |
4 | 35536 | 0.545 |
8 | 158059 | 0.540 |
3 | 46869 | 0.535 |
6 | 173766 | 0.530 |
Price($) | Vol. | No. |
---|---|---|
0.555 | 22500 | 1 |
0.560 | 21428 | 1 |
0.565 | 45284 | 3 |
0.575 | 10268 | 1 |
0.585 | 41022 | 3 |
Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online